Evidence map›Paper›PMID 30996041›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2019

The time-controlled adaptive ventilation protocol: mechanistic approach to reducing ventilator-induced lung injury.

Michaela Kollisch-Singule, Penny Andrews, Joshua Satalin, Louis A Gatto, Gary F Nieman, Nader M Habashi

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michaela Kollisch-SinguleDept of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.ORCID https://orcid.org/0000-0001-9422-1063
Penny AndrewsDept of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Joshua SatalinDept of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA satalinj@upstate.edu.
Louis A GattoDept of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Gary F NiemanDept of Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Nader M HabashiDept of Trauma Critical Care Medicine, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD, USA.
SUNY Upstate Medical University · USUniversity of Maryland, Baltimore · US

Funding

Development of a gene therapy approach to treat acute lung injury using a preclinical, large animal modelR01HL131143 · NHLBI · UNIVERSITY OF ROCHESTER · PI DEAN, DAVID A · 2016 to 2019
$3.0M
NHLBI NIH HHS R01 HL131143
6 · The paper itself

Abstract

Airway pressure release ventilation (APRV) is a ventilator mode that has previously been considered a rescue mode, but has gained acceptance as a primary mode of ventilation. In clinical series and experimental animal models of extrapulmonary acute respiratory distress syndrome (ARDS), the early application of APRV was able to prevent the development of ARDS. Recent experimental evidence has suggested mechanisms by which APRV, using the time-controlled adaptive ventilation (TCAV) protocol, may reduce lung injury, including: 1) an improvement in alveolar recruitment and homogeneity; 2) reduction in alveolar and alveolar duct micro-strain and stress-risers; 3) reduction in alveolar tidal volumes; and 4) recruitment of the chest wall by combating increased intra-abdominal pressure. This review examines these studies and discusses our current understanding of the pleiotropic mechanisms by which TCAV protects the lung. APRV set according to the TCAV protocol has been misunderstood and this review serves to highlight the various protective physiological and mechanical effects it has on the lung, so that its clinical application may be broadened.

Indexed as

Continuous Positive Airway PressureRespirationAnimalsHumansPulmonary AlveoliRespiration, ArtificialRespiratory Distress SyndromeRisk FactorsTime FactorsTreatment OutcomeVentilator-Induced Lung Injury

Identifiers

PMID30996041
PMCPMC9488504
OpenAlexW2938099154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.